CLASS II Device recall · Reported 6 Jan 2021 · FDA Enforcement Report

cobas pro integrated solutions -cobas c 503, Analyzer recalled

Roche Diagnostics Operations is recalling cobas pro integrated solutions -cobas c 503, Analyzer, chemistry (photometric discrete), distributed in Florida, Georgia, Illinois, West Virginia. The recall was initiated on 23 Nov 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number 08445605190 08445567190 08253153190 08058580190
Quantity recalled152 kits and 7 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0752-2021
FDA event ID
86897
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
23 Nov 2020
FDA classified
29 Dec 2020
Reported
6 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Labeling Errors

Timeline

23 Nov 2020Recall initiated by company
29 Dec 2020Classified by FDA+36 days
6 Jan 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the affected TDMs (Therapeutic Drug Monitoring).

Product as listed by the FDA

cobas pro integrated solutions -cobas c 503, Analyzer, chemistry (photometric discrete), for clinical use

Where it was distributed

Domestic: IL, FL, GA, WV

FloridaGeorgiaIllinoisWest Virginia

Questions about this recall

Why was it recalled?

During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the affected TDMs (Therapeutic Drug Monitoring).

Which lots are affected?

Catalog Number 08445605190 08445567190 08253153190 08058580190

Where was it sold?

Domestic: IL, FL, GA, WV

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Test Kits & Diagnostics recalls

All 2,663